Bernd Stahl

Title: Bernd Stahl: Innovator in Pharmaceutical Composition

Introduction

Bernd Stahl is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of pharmaceutical compositions, particularly in relation to nervous tissue and cardiovascular disorders. With a total of 2 patents, his work has the potential to impact various medical treatments.

Latest Patents

Stahl's latest patents include innovative approaches to the use of repulsive guidance molecule (RGM) and its modulators. The first patent focuses on the preparation of a pharmaceutical composition aimed at preventing, alleviating, or treating diseases associated with the degeneration or injury of vertebrate nervous tissue, seizures, and angiogenic disorders. The second patent also emphasizes the therapeutic use of antibodies directed against RGM, highlighting its role in treating similar conditions and even tumor growth.

Career Highlights

Bernd Stahl is affiliated with the Max Planck Society for the Advancement of Science, where he conducts his research and development. His work is characterized by a strong emphasis on the therapeutic applications of polypeptides and their derivatives.

Collaborations

Stahl has collaborated with esteemed colleagues such as Bernhard K. Mueller and Philippe Patrick Monnier, contributing to a rich environment of innovation and research.

Conclusion

Bernd Stahl's contributions to the field of pharmaceutical compositions demonstrate his commitment to advancing medical science. His innovative patents reflect a deep understanding of complex biological systems and their potential therapeutic applications.